ATP13A2 variability in Taiwanese Parkinson's disease

Chiung Mei Chen, Chih Hsin Lin, Hsueh Fen Juan, Fen Ju Hu, Ya Chin Hsiao, Hsin Yi Chang, Chih Ying Chao, I. Cheng Chen, Li Ching Lee, Tsu Wei Wang, Ya Tang Chen, Yi Tsun Chen, Guey Jen Lee-Chen, Yih Ru Wu

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Mutations in ATP13A2 have been reported to associate with Parkinson's disease (PD). This study investigates the contribution of genetic variants in ATP13A2 to Taiwanese PD. ATP13A2 cDNA fragments from 65 early onset PD (onset <50 years) were sequenced. The identified variants were validated in a cohort of PD (n=493) and ethnically matched controls (n=585). A novel heterozygous G1014S, located at the conserved seventh transmembrane domain of ATP13A2 protein, was identified in an early onset PD patient, which was absent in 585 normal controls. Additionally, a reported heterozygous A746T was found in two PD patients and four controls. The clinical features and 99mTc-TRODAT-1 single photon emission computed tomography (SPECT) image of the patients carrying G1014S and A746T were similar to that of idiopathic PD. One normal control with A746T showed an asymmetric reduction of 99mT TRODAT-1 uptake in the right striatum. Under oxidative stress or apoptotic stimulus, lymphoblastoid cells carrying either A764T or G1014S showed increased caspase 3 activity compared with the controls. The rates of decay for G1014S and A746T proteins were more or less reduced in cycloheximide chase experiment. In silico modeling of G1014S exhibited a more stable feature than wild-type, and G1014S is mislocalized mainly in the intralysosomal space, which is coherent with the prediction of prohibiting N-myristoylation and membrane association. We therefore hypothesize that rare variants of ATP13A2 may contribute to PD susceptibility in Taiwan. The role played by ATP13A2 variants in PD remains to be clarified.

Original languageEnglish
Pages (from-to)720-729
Number of pages10
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume156
Issue number6
DOIs
Publication statusPublished - Sep 1 2011
Externally publishedYes

Fingerprint

Parkinson Disease
Disease Susceptibility
Cycloheximide
Single-Photon Emission-Computed Tomography
Taiwan
Caspase 3
Computer Simulation
Oxidative Stress
Complementary DNA
Mutation
Membranes
Proteins

Keywords

  • ATP13A2
  • Expression study
  • Mutation screening
  • Parkinson's disease
  • Protein structure modeling

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

ATP13A2 variability in Taiwanese Parkinson's disease. / Chen, Chiung Mei; Lin, Chih Hsin; Juan, Hsueh Fen; Hu, Fen Ju; Hsiao, Ya Chin; Chang, Hsin Yi; Chao, Chih Ying; Chen, I. Cheng; Lee, Li Ching; Wang, Tsu Wei; Chen, Ya Tang; Chen, Yi Tsun; Lee-Chen, Guey Jen; Wu, Yih Ru.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 156, No. 6, 01.09.2011, p. 720-729.

Research output: Contribution to journalArticle

Chen, CM, Lin, CH, Juan, HF, Hu, FJ, Hsiao, YC, Chang, HY, Chao, CY, Chen, IC, Lee, LC, Wang, TW, Chen, YT, Chen, YT, Lee-Chen, GJ & Wu, YR 2011, 'ATP13A2 variability in Taiwanese Parkinson's disease', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 156, no. 6, pp. 720-729. https://doi.org/10.1002/ajmg.b.31214
Chen, Chiung Mei ; Lin, Chih Hsin ; Juan, Hsueh Fen ; Hu, Fen Ju ; Hsiao, Ya Chin ; Chang, Hsin Yi ; Chao, Chih Ying ; Chen, I. Cheng ; Lee, Li Ching ; Wang, Tsu Wei ; Chen, Ya Tang ; Chen, Yi Tsun ; Lee-Chen, Guey Jen ; Wu, Yih Ru. / ATP13A2 variability in Taiwanese Parkinson's disease. In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2011 ; Vol. 156, No. 6. pp. 720-729.
@article{717e0f20fabc4661af4ad78c2fe4a594,
title = "ATP13A2 variability in Taiwanese Parkinson's disease",
abstract = "Mutations in ATP13A2 have been reported to associate with Parkinson's disease (PD). This study investigates the contribution of genetic variants in ATP13A2 to Taiwanese PD. ATP13A2 cDNA fragments from 65 early onset PD (onset <50 years) were sequenced. The identified variants were validated in a cohort of PD (n=493) and ethnically matched controls (n=585). A novel heterozygous G1014S, located at the conserved seventh transmembrane domain of ATP13A2 protein, was identified in an early onset PD patient, which was absent in 585 normal controls. Additionally, a reported heterozygous A746T was found in two PD patients and four controls. The clinical features and 99mTc-TRODAT-1 single photon emission computed tomography (SPECT) image of the patients carrying G1014S and A746T were similar to that of idiopathic PD. One normal control with A746T showed an asymmetric reduction of 99mT TRODAT-1 uptake in the right striatum. Under oxidative stress or apoptotic stimulus, lymphoblastoid cells carrying either A764T or G1014S showed increased caspase 3 activity compared with the controls. The rates of decay for G1014S and A746T proteins were more or less reduced in cycloheximide chase experiment. In silico modeling of G1014S exhibited a more stable feature than wild-type, and G1014S is mislocalized mainly in the intralysosomal space, which is coherent with the prediction of prohibiting N-myristoylation and membrane association. We therefore hypothesize that rare variants of ATP13A2 may contribute to PD susceptibility in Taiwan. The role played by ATP13A2 variants in PD remains to be clarified.",
keywords = "ATP13A2, Expression study, Mutation screening, Parkinson's disease, Protein structure modeling",
author = "Chen, {Chiung Mei} and Lin, {Chih Hsin} and Juan, {Hsueh Fen} and Hu, {Fen Ju} and Hsiao, {Ya Chin} and Chang, {Hsin Yi} and Chao, {Chih Ying} and Chen, {I. Cheng} and Lee, {Li Ching} and Wang, {Tsu Wei} and Chen, {Ya Tang} and Chen, {Yi Tsun} and Lee-Chen, {Guey Jen} and Wu, {Yih Ru}",
year = "2011",
month = "9",
day = "1",
doi = "10.1002/ajmg.b.31214",
language = "English",
volume = "156",
pages = "720--729",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - ATP13A2 variability in Taiwanese Parkinson's disease

AU - Chen, Chiung Mei

AU - Lin, Chih Hsin

AU - Juan, Hsueh Fen

AU - Hu, Fen Ju

AU - Hsiao, Ya Chin

AU - Chang, Hsin Yi

AU - Chao, Chih Ying

AU - Chen, I. Cheng

AU - Lee, Li Ching

AU - Wang, Tsu Wei

AU - Chen, Ya Tang

AU - Chen, Yi Tsun

AU - Lee-Chen, Guey Jen

AU - Wu, Yih Ru

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Mutations in ATP13A2 have been reported to associate with Parkinson's disease (PD). This study investigates the contribution of genetic variants in ATP13A2 to Taiwanese PD. ATP13A2 cDNA fragments from 65 early onset PD (onset <50 years) were sequenced. The identified variants were validated in a cohort of PD (n=493) and ethnically matched controls (n=585). A novel heterozygous G1014S, located at the conserved seventh transmembrane domain of ATP13A2 protein, was identified in an early onset PD patient, which was absent in 585 normal controls. Additionally, a reported heterozygous A746T was found in two PD patients and four controls. The clinical features and 99mTc-TRODAT-1 single photon emission computed tomography (SPECT) image of the patients carrying G1014S and A746T were similar to that of idiopathic PD. One normal control with A746T showed an asymmetric reduction of 99mT TRODAT-1 uptake in the right striatum. Under oxidative stress or apoptotic stimulus, lymphoblastoid cells carrying either A764T or G1014S showed increased caspase 3 activity compared with the controls. The rates of decay for G1014S and A746T proteins were more or less reduced in cycloheximide chase experiment. In silico modeling of G1014S exhibited a more stable feature than wild-type, and G1014S is mislocalized mainly in the intralysosomal space, which is coherent with the prediction of prohibiting N-myristoylation and membrane association. We therefore hypothesize that rare variants of ATP13A2 may contribute to PD susceptibility in Taiwan. The role played by ATP13A2 variants in PD remains to be clarified.

AB - Mutations in ATP13A2 have been reported to associate with Parkinson's disease (PD). This study investigates the contribution of genetic variants in ATP13A2 to Taiwanese PD. ATP13A2 cDNA fragments from 65 early onset PD (onset <50 years) were sequenced. The identified variants were validated in a cohort of PD (n=493) and ethnically matched controls (n=585). A novel heterozygous G1014S, located at the conserved seventh transmembrane domain of ATP13A2 protein, was identified in an early onset PD patient, which was absent in 585 normal controls. Additionally, a reported heterozygous A746T was found in two PD patients and four controls. The clinical features and 99mTc-TRODAT-1 single photon emission computed tomography (SPECT) image of the patients carrying G1014S and A746T were similar to that of idiopathic PD. One normal control with A746T showed an asymmetric reduction of 99mT TRODAT-1 uptake in the right striatum. Under oxidative stress or apoptotic stimulus, lymphoblastoid cells carrying either A764T or G1014S showed increased caspase 3 activity compared with the controls. The rates of decay for G1014S and A746T proteins were more or less reduced in cycloheximide chase experiment. In silico modeling of G1014S exhibited a more stable feature than wild-type, and G1014S is mislocalized mainly in the intralysosomal space, which is coherent with the prediction of prohibiting N-myristoylation and membrane association. We therefore hypothesize that rare variants of ATP13A2 may contribute to PD susceptibility in Taiwan. The role played by ATP13A2 variants in PD remains to be clarified.

KW - ATP13A2

KW - Expression study

KW - Mutation screening

KW - Parkinson's disease

KW - Protein structure modeling

UR - http://www.scopus.com/inward/record.url?scp=80051565486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051565486&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.31214

DO - 10.1002/ajmg.b.31214

M3 - Article

C2 - 21714071

AN - SCOPUS:80051565486

VL - 156

SP - 720

EP - 729

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 6

ER -